Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-25-063806
Filing Date
2025-05-05
Accepted
2025-05-05 19:45:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4684
  Complete submission text file 0000950170-25-063806.txt   6357
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Subject) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36257 | Film No.: 25914718
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DRIVE, STE 300 SAN DIEGO CA 92130
Business Address
Cline Christopher R. (Reporting) CIK: 0001943192 (see all company filings)

Type: 144